About Us
Stangen Pharmaceuticals Philippines, Inc.
Standard, Advanced, Genuine, Novel
Stangen
Pharmaceuticals
Philippines, Inc.
Established in 2010, we have now moved from a registration for trade company to dynamic sales and marketing company.
We have a co-development model of business that concludes into mutually enriching multi-level co-operation leading to commercially beneficial relationship.
Stangen has rich portfolio of quality products that are already in leading positions across Philippines and are extremely enriching for the partners.
We are trusted partners of the medical fraternity, distinguished by products and unmatched services. Stangen is a company that has unparalleled skills to get into strategic partnerships with major pharmaceutical companies. We have people that have experience, that are highly trained and extremely committed and renowned in the pharmaceutical industry ━ nationally and internationally.
Stangen believes in high output professionals and provides service that is unparalled in Philippines beyond expectation.
Stangen
Pharmaceuticals
Philippines, Inc.
Established in 2010, we have now moved from a registration for trade company to dynamic sales and marketing company.
We have a co-development model of business that concludes into mutually enriching multi-level co-operation leading to commercially beneficial relationship.
Stangen has rich portfolio of quality products that are already in leading positions across Philippines and are extremely enriching for the partners.
We are trusted partners of the medical fraternity, distinguished by products and unmatched services. Stangen is a company that has unparalleled skills to get into strategic partnerships with major pharmaceutical companies. We have people that have experience, that are highly trained and extremely committed and renowned in the pharmaceutical industry ━ nationally and internationally.
Stangen believes in high output professionals and provides service that is unparalled in Philippines beyond expectation.
Our Vision
To provide premium pharmaceutical products to Filipino population at economical, reasonable and affordable prices.
We believe in being the FAST and FIRST in launch of “just” off patent products.
Our Mission
To continue to launch advanced and novel pharmaceutical products and be a trusted and reliable and genuine partner of choice as an integrated supply chain provider.
Stangen Pharmaceuticals Philippines, Inc.
Stangen is engaged in importation, distribution of pharmaceuticals acquired from licensing long term agreements with renowned principals from various parts of the world and are accredited with embellishments like:
- USFDA
- UKMHRA
- TGA EU
- RPFDA
- Corporate strengths
- Extensive understanding of the Philippine pharmaceutical market and then ability to adapt global marketing perspective to local culture and traditions
- Proven capability to successfully register both first filers, new products and mature products
- A history of successful long-term partnerships with national and international companies
- First company in Philippines to launch Esomeprazole and is a leader in terms of units
- First to launch auto-disabled syringes in Philippines
- First company to launch Ceftriaxone + Sulbactam and is selling close to 70,000 vials per annum. We are in search of PICS approved facility
- First company to launch Atorvastatin + Ezetimibe
- First company to Launch 1000 Mg Paracetamol SR.
- Our volumes per annum ending December 2015 were USD 4 Million
- Many firsts in the pipeline
Stangen is engaged in importation, distribution of pharmaceuticals acquired from licensing long term agreements with renowned principals from various parts of the world and are accredited with embellishments like:
- USFDA
- UKMHRA
- TGA EU
- RPFDA
- Corporate strengths
- Extensive understanding of the Philippine pharmaceutical market and then ability to adapt global marketing perspective to local culture and traditions
- Proven capability to successfully register both first filers, new products and mature products
- A history of successful long-term partnerships with national and international companies
- First company in Philippines to launch Esomeprazole and is a leader in terms of units
- First to launch auto-disabled syringes in Philippines
- First company to launch Ceftriaxone + Sulbactam and is selling close to 70,000 vials per annum. We are in search of PICS approved facility
- First company to launch Atorvastatin + Ezetimibe
- First company to Launch 1000 Mg Paracetamol SR.
- Our volumes per annum ending December 2015 were USD 4 Million
- Many firsts in the pipeline
Philippine Pharmaceutical Industry
The Philippine pharmaceutical market has total value of approximately US$4.5b ( with similar growth of 9% for the past three years. MNC’s value shares remain stable, however, national companies are significantly climbing up the ranks. Causes of mortality and morbidity remains the same; trending is reflected in top therapeutic categories. The US$2.5 billion Philippine pharmaceutical market is growing at around 9% annually.
Top causes of mortality and morbidity continue to be respiratory and cardiovascular diseases, which is reflected in strong demand for drugs in these categories.
About 80% of the products are sold through drugstores, about 10% through the hospitals and another 10% through government institutions, dispensing physicians.
Branded products account for 97% of drugs sold and generic products for 3%
Multinational companies account for approximately 65% with national companies meeting 35% of the demand.
Our Journey
100
CPRS
40
SUPPLIERS
Pharmacovigilance
Corporate Social Responsibility
Stangen shares and cares for the needy and with this mission donated several 100’s of boxes of medicines for Yolanda victims in 2012 and 2013.
Stangen vows to share and care every step of the way for the needy.
Corporate Strength
Extensive understanding of the Philippine pharmaceutical market and the ability to adapt global marketing perspective to local culture and traditions.
We have proven capability to successfully register both first filers, new products and mature products. Stangen shares its gains with awards and rewards for performers.
Stangen has a rich roster of products and has filed well over 100 applications to FDA Philippines thus ensures short, medium and long term success with the medical fraternity and is a reliable partner for the willing reputed pharmaceutical companies from across the globe.
Company Process
Stangen Pharmaceuticals Philippines, Inc.
Standard, Advanced, Genuine, Novel
Bioequivalent biopharmaceuticals from companies that are embellished with USFDA, UKMHRA, Australian TGA, French FDA, GMP compliant, exporting to several countries including the “Pearl of the Orient” The Republic of Philippines with approval from Food and Drug Administration (FDA).
Our products come from reputable and quality sources and reputation of the manufacturer is an important parameter in promotion, marketing and sales of a product in the republic.
Business Model
- Our model of business
- Registration
- Agreement with binding forecast and supply agreement
- Create certificate listing of identical product for affiliates where ever needed to assist the manufacturer to enhance sales and reach out deeper into the Republic of Philippines an archipelago of 7107 Islands
- Import
- Supply from reputed suppliers
Business Process
Agreement:
- Selection of the product
- CLIDP
- Goods in warehouse in about 45 to 60 days from the date of formalization of the agreement
- Subsequent deliveries in about 30 to 45 days
Marketing Support
- Bioequivalence Study papers wherever mandated
We are trusted partners of the medical fraternity distinguished by products and unmatched services.
Stangen is a company that has unparalleled skills to get into strategic partnerships with major pharmaceutical companies.
Our Services
- Patent Research, Assessment and Evaluation
- Commercial Research
- Registration of the Product as per various classifications such as “Innovator”, Monitored release, and the rest
- Warehousing